ATE258793T1 - 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom - Google Patents

5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom

Info

Publication number
ATE258793T1
ATE258793T1 AT00978627T AT00978627T ATE258793T1 AT E258793 T1 ATE258793 T1 AT E258793T1 AT 00978627 T AT00978627 T AT 00978627T AT 00978627 T AT00978627 T AT 00978627T AT E258793 T1 ATE258793 T1 AT E258793T1
Authority
AT
Austria
Prior art keywords
agonists
agent
treating glaucoma
eye pressure
controlling eye
Prior art date
Application number
AT00978627T
Other languages
English (en)
Inventor
Jesse A May
Anura P Dantanarayana
Original Assignee
Alcon Inc
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc, Yamanouchi Pharma Co Ltd filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE258793T1 publication Critical patent/ATE258793T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00978627T 2000-03-17 2000-11-14 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom ATE258793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19028800P 2000-03-17 2000-03-17
PCT/US2000/031246 WO2001070207A2 (en) 2000-03-17 2000-11-14 5ht2 agonists for controlling iop and treating glaucoma

Publications (1)

Publication Number Publication Date
ATE258793T1 true ATE258793T1 (de) 2004-02-15

Family

ID=22700724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978627T ATE258793T1 (de) 2000-03-17 2000-11-14 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom

Country Status (19)

Country Link
EP (1) EP1267847B1 (de)
JP (1) JP2003527415A (de)
KR (1) KR100499903B1 (de)
CN (1) CN1231214C (de)
AR (1) AR026707A1 (de)
AT (1) ATE258793T1 (de)
AU (2) AU2001216071B2 (de)
BR (1) BR0017158A (de)
CA (1) CA2401969A1 (de)
DE (1) DE60008151T2 (de)
DK (1) DK1267847T3 (de)
ES (1) ES2210018T3 (de)
MX (1) MXPA02008548A (de)
PL (1) PL358296A1 (de)
PT (1) PT1267847E (de)
TR (1) TR200400424T4 (de)
TW (1) TW546139B (de)
WO (1) WO2001070207A2 (de)
ZA (1) ZA200206852B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
WO2004054572A2 (en) 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US6989445B2 (en) 2003-12-15 2006-01-24 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US8685924B2 (en) 2004-08-25 2014-04-01 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
EP2018863B9 (de) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Kondensierte, heterocyclische Verbindung und ihre Verwendung
EP2789338A3 (de) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Kondensiertes Pyridinderivat und seine Verwendung
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030548A1 (en) * 1997-01-13 1998-07-16 Yamanouchi Pharmaceutical Co., Ltd. 5-HT2c RECEPTOR AGONISTS AND AMINOALKYLINDAZOLE DERIVATIVES
AU2042301A (en) * 1999-12-03 2001-06-12 Alcon Universal Limited 1-aminoalkyl-1H-indoles for treating glaucoma

Also Published As

Publication number Publication date
KR20030095185A (ko) 2003-12-18
HK1050143A1 (en) 2003-06-13
WO2001070207A3 (en) 2002-05-10
CN1450897A (zh) 2003-10-22
WO2001070207A2 (en) 2001-09-27
DE60008151T2 (de) 2004-07-08
TW546139B (en) 2003-08-11
TR200400424T4 (tr) 2004-03-22
PT1267847E (pt) 2004-05-31
ZA200206852B (en) 2003-08-27
CA2401969A1 (en) 2001-09-27
EP1267847B1 (de) 2004-02-04
AU2001216071B2 (en) 2004-12-02
PL358296A1 (en) 2004-08-09
MXPA02008548A (es) 2004-08-23
DE60008151D1 (de) 2004-03-11
AU1607101A (en) 2001-10-03
BR0017158A (pt) 2003-06-03
CN1231214C (zh) 2005-12-14
AR026707A1 (es) 2003-02-26
EP1267847A2 (de) 2003-01-02
JP2003527415A (ja) 2003-09-16
KR100499903B1 (ko) 2005-07-07
ES2210018T3 (es) 2004-07-01
DK1267847T3 (da) 2004-03-08

Similar Documents

Publication Publication Date Title
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
DE60120667D1 (de) Methoden und mittel zur behandlung von bandscheibenverschleiss
ATE258793T1 (de) 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
MXPA03001960A (es) Un metodo para tratar alergias.
DE60101265D1 (de) Behandlung von augenschmerzen
ATE296628T1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
DE60021908D1 (de) Hydroxyeicosatetraenoatsalze, zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
ATE375141T1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
EP1506001A4 (de) Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
EP1441761A4 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
WO2004091436A3 (en) Methods and compositions for treating ocular disease
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60231246D1 (de) Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
ATE409491T1 (de) Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
BRPI0607684A2 (pt) composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1267847

Country of ref document: EP

REN Ceased due to non-payment of the annual fee